Raw Material Capecitabine 99% Purity Pharmaceutical Capecitabine Powder Raw Powder Capecitabine

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung-Capecitabine
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Product Name: Capecitabine
• Name: Capecitabine Powder
• Appearance: White Powder
• Color: White Color
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Grade
• Specific: COA
• Test Method: HPLC UV
• CAS No: 154361-50-9
• Mf: C15h22fn3o6
• MW: 359.35
• Density: 1.49
• Melting Point: 110
• Boiling Point: 437.874
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 5000kg/Month

Product Description

Raw material Capecitabine 99% Purity Pharmaceutical Capecitabine powder Raw Powder Capecitabine 

Product Description

Product Datails

Product name	Capecitabine
CAS	154361-50-9
MW	359.350
Density	1.5±0.1 g/cm3
MF	C15H22FN3O6
Assay	99%
BP	517.6±60.0 °C at 760 mmHg
MP	110-121°C
FP	266.8±32.9 °C

Capecitabine is a fluoropyrimidine carbamate belonging to the class of antineoplastic agents called antimetabolites. As a prodrug, capecitabine is selectively activated by tumor cells to its cytotoxic moiety, 5-fluorouracil (5-FU); subsequently, 5-FU is metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP) by both tumor cells and normal cells. FdUMP inhibits DNA synthesis and cell division by reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate for incorporation into the RNA strand.

Application&Function

For the treatment of patients with metastatic breast cancer resistant to both paclitaxel and an anthracycline-containing chemotherapy regimen. May also be used in combination with docetaxel for the treatment of metastatic breast cancer in patients who have failed to respond to, or recurred or relasped during or following anthracycline-containing chemotherapy. Capecitabine is used alone as an adjuvant therapy following the complete resection of primary tumor in patients with stage III colon cancer when monotherapy with fluroprymidine is preferred. The use or capecitabine in combination regimens for advanced gastric cancer is currently being investigated.

Specification